Effects of hormonal contraception on bone mineral density after 24 months of use

被引:72
|
作者
Berenson, AB
Breitkopf, CR
Grady, JJ
Rickert, VI
Thomas, A
机构
[1] Univ Texas, Dept Obstet & Gynecol, Med Branch, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77550 USA
[3] Wilford Hall USAF Med Ctr, San Antonio, TX 78236 USA
来源
OBSTETRICS AND GYNECOLOGY | 2004年 / 103卷 / 05期
关键词
D O I
10.1097/01.AOG.0000117082.49490.d5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To measure the effect of 24 months of depot medroxyprogesterone acetate use on bone mineral density compared with oral contraception (pills) and nonhormonal contraception. METHODS: Women aged 18-33 years self-selected oral contraception, depot medroxyprogesterone acetate, or nonhormonal contraception (controls). Those selecting pills were randomized to formulations containing either 35 mug ethinyl estradiol and norethindrone or 30 mug ethinyl estradiol and desogestrel. Controls were frequency matched on age and race/ethnicity to hormonal contraception users. Dual-energy X-ray absorptiometry of the lumbar spine (L1-L4) was performed at baseline, 12 months, and 24 months. Percent change in bone mineral density was analyzed by using analysis of covariance, adjusting for age, race/ethnicity, weight-bearing exercise, calcium intake, smoking status, and body mass index. RESULTS: Of the 191 women making up the final sample, 86 used pills, 47 used depot medroxyprogesterone acetate, and 58 used nonhormonal contraception. Women using depot medroxyprogesterone acetate for 24 months experienced, on average, a 5.7% loss in bone mineral density, with a 3.2% loss occurring between months 12 and 24. On average, users of desogestrel pills experienced a 2.6% loss in bone mineral density after 24 months. Bonferroni-adjusted pairwise comparisons demonstrated that bone mineral density changes from baseline to 24 months among depot medroxyprogesterone acetate users differed significantly from changes experienced by either of the pill groups or the control group. Changes in bone mineral density among users of either pill did not significantly differ from each other or from controls. CONCLUSION: Loss of bone mineral density associated with depot medroxyprogesterone acetate use appears to be linear during the first 2 years of use. Shifts in bone mineral density among pill users were not significant when compared with controls. ( (C) 2004 by The American College of Obstetricians and Gynecologists.).
引用
收藏
页码:899 / 906
页数:8
相关论文
共 50 条
  • [31] Bone mineral density changes in young African women on tenofovir disoproxil fumarate antiretroviral therapy and non-hormonal contraception
    Matovu, F. K.
    Kiwanuka, N.
    Nabwana, M.
    Isingel, E.
    Fowler, M. G.
    Nolan, M. L.
    Musoke, P.
    Pettifor, J. M.
    Beksinska, M.
    Brown, T. T.
    HIV MEDICINE, 2019, 20 : 143 - 144
  • [32] Bone mineral density in midlife long-term users of hormonal contraception in South Africa: relationship with obesity and menopausal status
    Mags E. Beksinska
    Immo Kleinschmidt
    Jenni A. Smit
    Women's Midlife Health, 4 (1)
  • [33] Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease?
    Merki-Feld, Gabriele Susanne
    Bitzer, Johannes
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2020, 25 (03): : 213 - 220
  • [34] Stimulant Use and Bone Mineral Density
    Poulton, Alison
    Lee, Karen N. W.
    JAMA PEDIATRICS, 2017, 171 (05) : 494 - 495
  • [35] Resolution of Effects On Bone Turnover Markers and Bone Mineral Density After Discontinuation of Long-Term Bisphosphonate Use
    Saag, Kenneth G.
    Benhamou, Claude-Laurent
    De Villiers, Tobias
    Johnston, C. Conrad, Jr.
    Langdahl, Bente
    Denker, Andrew
    Pong, Annpey
    McGinnis, John P.
    Rosenberg, Elizabeth
    Santora, Arthur
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S835 - S836
  • [36] Bone mineral density in women using depot medroxyprogesterone acetate for contraception
    Scholes, D
    Lacroix, AZ
    Ott, SM
    Ichikawa, LE
    Barlow, WE
    OBSTETRICS AND GYNECOLOGY, 1999, 93 (02): : 233 - 238
  • [37] Progestogen-only contraception and bone mineral density: a systematic review
    Curtis, KM
    Martins, SL
    CONTRACEPTION, 2006, 73 (05) : 470 - 487
  • [38] Remarkable loss of bone mineral density in 6 months after denosumab discontinuation: a case report
    Maezumi, Yusuke
    Kamimura, Mikio
    Nakamura, Yukio
    Takahashi, Jun
    MODERN RHEUMATOLOGY CASE REPORTS, 2020, 4 (02) : 218 - 221
  • [39] Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls
    Lattakova, M.
    Borovsky, M.
    Payer, J.
    Killinger, Z.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2009, 14 (03): : 207 - 214
  • [40] EFFECTS OF TOBACCO USE ON AXIAL AND APPENDICULAR BONE-MINERAL DENSITY
    POCOCK, NA
    EISMAN, JA
    KELLY, PJ
    SAMBROOK, PN
    YEATES, MG
    BONE, 1989, 10 (05) : 329 - 331